EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy JG Paez, PA Janne, JC Lee, S Tracy, H Greulich, S Gabriel, P Herman, ... Science 304 (5676), 1497-1500, 2004 | 12008 | 2004 |
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ... Nature 483 (7391), 603-607, 2012 | 7855 | 2012 |
The landscape of somatic copy-number alteration across human cancers R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ... Nature 463 (7283), 899-905, 2010 | 4285 | 2010 |
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis RL Levine, M Wadleigh, J Cools, BL Ebert, G Wernig, BJP Huntly, ... Cancer cell 7 (4), 387-397, 2005 | 3844 | 2005 |
Gene expression correlates of clinical prostate cancer behavior D Singh, PG Febbo, K Ross, DG Jackson, J Manola, C Ladd, P Tamayo, ... Cancer cell 1 (2), 203-209, 2002 | 3135 | 2002 |
Next-generation characterization of the cancer cell line encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503-508, 2019 | 2503 | 2019 |
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma LA Garraway, HR Widlund, MA Rubin, G Getz, AJ Berger, S Ramaswamy, ... Nature 436 (7047), 117-122, 2005 | 1783 | 2005 |
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation CM Johannessen, JS Boehm, SY Kim, SR Thomas, L Wardwell, ... Nature 468 (7326), 968-972, 2010 | 1724 | 2010 |
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors IK Mellinghoff, MY Wang, I Vivanco, DA Haas-Kogan, S Zhu, EQ Dia, ... New England Journal of Medicine 353 (19), 2012-2024, 2005 | 1721 | 2005 |
Molecular characterization of the tumor microenvironment in breast cancer M Allinen, R Beroukhim, L Cai, C Brennan, J Lahti-Domenici, H Huang, ... Cancer cell 6 (1), 17-32, 2004 | 1572 | 2004 |
BRAF mutation predicts sensitivity to MEK inhibition DB Solit, LA Garraway, CA Pratilas, A Sawai, G Getz, A Basso, Q Ye, ... Nature 439 (7074), 358-362, 2006 | 1540 | 2006 |
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo … SM Maira, F Stauffer, J Brueggen, P Furet, C Schnell, C Fritsch, ... Molecular cancer therapeutics 7 (7), 1851-1863, 2008 | 1350 | 2008 |
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response H Gao, JM Korn, S Ferretti, JE Monahan, Y Wang, M Singh, C Zhang, ... Nature medicine 21 (11), 1318-1325, 2015 | 1347 | 2015 |
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway I Sansal, WR Sellers Journal of clinical oncology 22 (14), 2954-2963, 2004 | 1255 | 2004 |
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma R Beroukhim, G Getz, L Nghiemphu, J Barretina, T Hsueh, D Linhart, ... Proceedings of the National Academy of Sciences 104 (50), 20007-20012, 2007 | 1238 | 2007 |
High-throughput oncogene mutation profiling in human cancer RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ... Nature genetics 39 (3), 347-351, 2007 | 1166 | 2007 |
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways PK Majumder, PG Febbo, R Bikoff, R Berger, Q Xue, LM McMahon, ... Nature medicine 10 (6), 594-601, 2004 | 1139 | 2004 |
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties WG Kaelin Jr, W Krek, WR Sellers, JA DeCaprio, F Ajchenbaum, ... Cell 70 (2), 351-364, 1992 | 1060 | 1992 |
Phosphorylation of the PTEN tail regulates protein stability and function F Vazquez, S Ramaswamy, N Nakamura, WR Sellers Molecular and cellular biology 20 (14), 5010-5018, 2000 | 955 | 2000 |
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage ME McMenamin, P Soung, S Perera, I Kaplan, M Loda, WR Sellers Cancer research 59 (17), 4291-4296, 1999 | 924 | 1999 |